4/9
08:09 am
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
Low
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
4/9
06:15 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
4/9
06:15 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
3/7
08:02 am
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $45.00 price target on the stock.
Low
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $45.00 price target on the stock.
3/7
05:00 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
3/4
08:06 am
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Low
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
3/1
06:20 pm
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) was upgraded by analysts at TheStreet from a "d+" rating to a "c" rating.
Low
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) was upgraded by analysts at TheStreet from a "d+" rating to a "c" rating.
3/1
10:34 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
3/1
10:34 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
3/1
08:15 am
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
Medium
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
3/1
05:28 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
3/1
05:28 am
pcrx
Rating for PCRX
Low
Report
Rating for PCRX
2/8
08:32 am
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Medium
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
2/8
08:32 am
pcrx
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Medium
Report
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
2/8
08:30 am
pcrx
Rating for PCRX
Medium
Report
Rating for PCRX
2/8
08:30 am
pcrx
Rating for PCRX
Medium
Report
Rating for PCRX